441 related articles for article (PubMed ID: 21074634)
1. The graphical representation of ADME-related molecule properties for medicinal chemists.
Ritchie TJ; Ertl P; Lewis R
Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
[TBL] [Abstract][Full Text] [Related]
2. Applications of high-throughput ADME in drug discovery.
Kassel DB
Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
[TBL] [Abstract][Full Text] [Related]
3. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
Meanwell NA
Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
[TBL] [Abstract][Full Text] [Related]
4. In silico pKa prediction and ADME profiling.
Cruciani G; Milletti F; Storchi L; Sforna G; Goracci L
Chem Biodivers; 2009 Nov; 6(11):1812-21. PubMed ID: 19937818
[TBL] [Abstract][Full Text] [Related]
5. Calculation and application of activity discriminants in lead optimization.
Luo X; Krumrine JR; Shenvi AB; Pierson ME; Bernstein PR
J Mol Graph Model; 2010 Nov; 29(3):372-81. PubMed ID: 20800520
[TBL] [Abstract][Full Text] [Related]
6. Intramolecular hydrogen bonding in medicinal chemistry.
Kuhn B; Mohr P; Stahl M
J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530
[TBL] [Abstract][Full Text] [Related]
7. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
Dobson PD; Patel Y; Kell DB
Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
[TBL] [Abstract][Full Text] [Related]
8. Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability.
Nassar AE; Kamel AM; Clarimont C
Drug Discov Today; 2004 Dec; 9(23):1020-8. PubMed ID: 15574318
[TBL] [Abstract][Full Text] [Related]
9. Improving compound quality through in vitro and in silico physicochemical profiling.
van de Waterbeemd H
Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
[TBL] [Abstract][Full Text] [Related]
10. Lead optimization in the nondrug-like space.
Zhao H
Drug Discov Today; 2011 Feb; 16(3-4):158-63. PubMed ID: 21147254
[TBL] [Abstract][Full Text] [Related]
11. Lead-oriented synthesis: a new opportunity for synthetic chemistry.
Nadin A; Hattotuwagama C; Churcher I
Angew Chem Int Ed Engl; 2012 Jan; 51(5):1114-22. PubMed ID: 22271624
[TBL] [Abstract][Full Text] [Related]
12. The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types.
Ritchie TJ; Macdonald SJ; Young RJ; Pickett SD
Drug Discov Today; 2011 Feb; 16(3-4):164-71. PubMed ID: 21129497
[TBL] [Abstract][Full Text] [Related]
13. How well do medicinal chemists learn from experience?
Cheshire DR
Drug Discov Today; 2011 Sep; 16(17-18):817-21. PubMed ID: 21704183
[TBL] [Abstract][Full Text] [Related]
14. A practical view of 'druggability'.
Keller TH; Pichota A; Yin Z
Curr Opin Chem Biol; 2006 Aug; 10(4):357-61. PubMed ID: 16814592
[TBL] [Abstract][Full Text] [Related]
15. Strategies and tactics for optimizing the Hit-to-Lead process and beyond--a computational chemistry perspective.
Manly CJ; Chandrasekhar J; Ochterski JW; Hammer JD; Warfield BB
Drug Discov Today; 2008 Feb; 13(3-4):99-109. PubMed ID: 18275907
[TBL] [Abstract][Full Text] [Related]
16. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
Guo ZR
Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
[TBL] [Abstract][Full Text] [Related]
17. Designing active template molecules by combining computational de novo design and human chemist's expertise.
Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
[TBL] [Abstract][Full Text] [Related]
18. Development of specific "drug-like property" rules for carboxylate-containing oral drug candidates.
Böcker A; Bonneau PR; Hucke O; Jakalian A; Edwards PJ
ChemMedChem; 2010 Dec; 5(12):2102-13. PubMed ID: 20979082
[TBL] [Abstract][Full Text] [Related]
19. Evolving molecules using multi-objective optimization: applying to ADME/Tox.
Ekins S; Honeycutt JD; Metz JT
Drug Discov Today; 2010 Jun; 15(11-12):451-60. PubMed ID: 20438859
[TBL] [Abstract][Full Text] [Related]
20. Design strategies for building drug-like chemical libraries.
Mitchell T; Showell GA
Curr Opin Drug Discov Devel; 2001 May; 4(3):314-8. PubMed ID: 11560064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
